0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Specific Antigen Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36E7077
Home | Market Reports | Health| Men s Health
Global Prostate Specific Antigen Market Insights Forecast to 2028
BUY CHAPTERS

Global Prostate Specific Antigen Market Research Report 2025

Code: QYRE-Auto-36E7077
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prostate Specific Antigen Market

The global market for Prostate Specific Antigen was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Prostate Specific Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prostate Specific Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prostate Specific Antigen include Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc., OncBioMune Pharmaceuticals Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen.
The Prostate Specific Antigen market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Specific Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Specific Antigen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prostate Specific Antigen Market Report

Report Metric Details
Report Name Prostate Specific Antigen Market
Segment by Type
  • G-115
  • INO-5150
  • ADXS-PSA
  • AEZS-120
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc., OncBioMune Pharmaceuticals Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostate Specific Antigen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostate Specific Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prostate Specific Antigen Market report?

Ans: The main players in the Prostate Specific Antigen Market are Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc., OncBioMune Pharmaceuticals Inc.

What are the Application segmentation covered in the Prostate Specific Antigen Market report?

Ans: The Applications covered in the Prostate Specific Antigen Market report are Prostate Cancer, Metastatic Hormone Refractory Prostate Cancer, Others

What are the Type segmentation covered in the Prostate Specific Antigen Market report?

Ans: The Types covered in the Prostate Specific Antigen Market report are G-115, INO-5150, ADXS-PSA, AEZS-120, Others

Recommended Reports

Prostate Cancer Markets

Cancer Antigen Therapy

Vaccines & Immunotherapy

1 Prostate Specific Antigen Market Overview
1.1 Product Definition
1.2 Prostate Specific Antigen by Type
1.2.1 Global Prostate Specific Antigen Market Value Comparison by Type (2024 VS 2031)
1.2.2 G-115
1.2.3 INO-5150
1.2.4 ADXS-PSA
1.2.5 AEZS-120
1.2.6 Others
1.3 Prostate Specific Antigen by Application
1.3.1 Global Prostate Specific Antigen Market Value by Application (2024 VS 2031)
1.3.2 Prostate Cancer
1.3.3 Metastatic Hormone Refractory Prostate Cancer
1.3.4 Others
1.4 Global Prostate Specific Antigen Market Size Estimates and Forecasts
1.4.1 Global Prostate Specific Antigen Revenue 2020-2031
1.4.2 Global Prostate Specific Antigen Sales 2020-2031
1.4.3 Global Prostate Specific Antigen Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostate Specific Antigen Market Competition by Manufacturers
2.1 Global Prostate Specific Antigen Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostate Specific Antigen Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostate Specific Antigen Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostate Specific Antigen, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostate Specific Antigen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Specific Antigen, Product Type & Application
2.7 Global Key Manufacturers of Prostate Specific Antigen, Date of Enter into This Industry
2.8 Global Prostate Specific Antigen Market Competitive Situation and Trends
2.8.1 Global Prostate Specific Antigen Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostate Specific Antigen Players Market Share by Revenue
2.8.3 Global Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostate Specific Antigen Market Scenario by Region
3.1 Global Prostate Specific Antigen Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostate Specific Antigen Sales by Region: 2020-2031
3.2.1 Global Prostate Specific Antigen Sales by Region: 2020-2025
3.2.2 Global Prostate Specific Antigen Sales by Region: 2026-2031
3.3 Global Prostate Specific Antigen Revenue by Region: 2020-2031
3.3.1 Global Prostate Specific Antigen Revenue by Region: 2020-2025
3.3.2 Global Prostate Specific Antigen Revenue by Region: 2026-2031
3.4 North America Prostate Specific Antigen Market Facts & Figures by Country
3.4.1 North America Prostate Specific Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostate Specific Antigen Sales by Country (2020-2031)
3.4.3 North America Prostate Specific Antigen Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Specific Antigen Market Facts & Figures by Country
3.5.1 Europe Prostate Specific Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostate Specific Antigen Sales by Country (2020-2031)
3.5.3 Europe Prostate Specific Antigen Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Region
3.6.1 Asia Pacific Prostate Specific Antigen Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostate Specific Antigen Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostate Specific Antigen Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prostate Specific Antigen Market Facts & Figures by Country
3.7.1 Latin America Prostate Specific Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostate Specific Antigen Sales by Country (2020-2031)
3.7.3 Latin America Prostate Specific Antigen Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Specific Antigen Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostate Specific Antigen Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostate Specific Antigen Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Specific Antigen Sales by Type (2020-2031)
4.1.1 Global Prostate Specific Antigen Sales by Type (2020-2025)
4.1.2 Global Prostate Specific Antigen Sales by Type (2026-2031)
4.1.3 Global Prostate Specific Antigen Sales Market Share by Type (2020-2031)
4.2 Global Prostate Specific Antigen Revenue by Type (2020-2031)
4.2.1 Global Prostate Specific Antigen Revenue by Type (2020-2025)
4.2.2 Global Prostate Specific Antigen Revenue by Type (2026-2031)
4.2.3 Global Prostate Specific Antigen Revenue Market Share by Type (2020-2031)
4.3 Global Prostate Specific Antigen Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prostate Specific Antigen Sales by Application (2020-2031)
5.1.1 Global Prostate Specific Antigen Sales by Application (2020-2025)
5.1.2 Global Prostate Specific Antigen Sales by Application (2026-2031)
5.1.3 Global Prostate Specific Antigen Sales Market Share by Application (2020-2031)
5.2 Global Prostate Specific Antigen Revenue by Application (2020-2031)
5.2.1 Global Prostate Specific Antigen Revenue by Application (2020-2025)
5.2.2 Global Prostate Specific Antigen Revenue by Application (2026-2031)
5.2.3 Global Prostate Specific Antigen Revenue Market Share by Application (2020-2031)
5.3 Global Prostate Specific Antigen Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Advaxis, Inc.
6.1.1 Advaxis, Inc. Company Information
6.1.2 Advaxis, Inc. Description and Business Overview
6.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Advaxis, Inc. Prostate Specific Antigen Product Portfolio
6.1.5 Advaxis, Inc. Recent Developments/Updates
6.2 Aeterna Zentaris Inc.
6.2.1 Aeterna Zentaris Inc. Company Information
6.2.2 Aeterna Zentaris Inc. Description and Business Overview
6.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio
6.2.5 Aeterna Zentaris Inc. Recent Developments/Updates
6.3 Bavarian Nordic A/S
6.3.1 Bavarian Nordic A/S Company Information
6.3.2 Bavarian Nordic A/S Description and Business Overview
6.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio
6.3.5 Bavarian Nordic A/S Recent Developments/Updates
6.4 Curevac AG
6.4.1 Curevac AG Company Information
6.4.2 Curevac AG Description and Business Overview
6.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Curevac AG Prostate Specific Antigen Product Portfolio
6.4.5 Curevac AG Recent Developments/Updates
6.5 GenSpera, Inc.
6.5.1 GenSpera, Inc. Company Information
6.5.2 GenSpera, Inc. Description and Business Overview
6.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GenSpera, Inc. Prostate Specific Antigen Product Portfolio
6.5.5 GenSpera, Inc. Recent Developments/Updates
6.6 Inovio Pharmaceuticals, Inc.
6.6.1 Inovio Pharmaceuticals, Inc. Company Information
6.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio
6.6.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates
6.7 OncBioMune Pharmaceuticals Inc.
6.7.1 OncBioMune Pharmaceuticals Inc. Company Information
6.7.2 OncBioMune Pharmaceuticals Inc. Description and Business Overview
6.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio
6.7.5 OncBioMune Pharmaceuticals Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Specific Antigen Industry Chain Analysis
7.2 Prostate Specific Antigen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Specific Antigen Production Mode & Process Analysis
7.4 Prostate Specific Antigen Sales and Marketing
7.4.1 Prostate Specific Antigen Sales Channels
7.4.2 Prostate Specific Antigen Distributors
7.5 Prostate Specific Antigen Customer Analysis
8 Prostate Specific Antigen Market Dynamics
8.1 Prostate Specific Antigen Industry Trends
8.2 Prostate Specific Antigen Market Drivers
8.3 Prostate Specific Antigen Market Challenges
8.4 Prostate Specific Antigen Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Prostate Specific Antigen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostate Specific Antigen Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostate Specific Antigen Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostate Specific Antigen Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Prostate Specific Antigen Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostate Specific Antigen Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostate Specific Antigen Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostate Specific Antigen Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostate Specific Antigen, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostate Specific Antigen, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostate Specific Antigen, Product Type & Application
 Table 12. Global Key Manufacturers of Prostate Specific Antigen, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostate Specific Antigen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostate Specific Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostate Specific Antigen Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Prostate Specific Antigen Sales Market Share by Region (2020-2025)
 Table 19. Global Prostate Specific Antigen Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Prostate Specific Antigen Sales Market Share by Region (2026-2031)
 Table 21. Global Prostate Specific Antigen Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostate Specific Antigen Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostate Specific Antigen Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostate Specific Antigen Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostate Specific Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Prostate Specific Antigen Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Prostate Specific Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostate Specific Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostate Specific Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Prostate Specific Antigen Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Prostate Specific Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostate Specific Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostate Specific Antigen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostate Specific Antigen Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Prostate Specific Antigen Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Prostate Specific Antigen Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostate Specific Antigen Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostate Specific Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Prostate Specific Antigen Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Prostate Specific Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostate Specific Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostate Specific Antigen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostate Specific Antigen Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Prostate Specific Antigen Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Prostate Specific Antigen Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostate Specific Antigen Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostate Specific Antigen Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Prostate Specific Antigen Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Prostate Specific Antigen Sales Market Share by Type (2020-2025)
 Table 53. Global Prostate Specific Antigen Sales Market Share by Type (2026-2031)
 Table 54. Global Prostate Specific Antigen Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostate Specific Antigen Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostate Specific Antigen Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostate Specific Antigen Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostate Specific Antigen Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Prostate Specific Antigen Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Prostate Specific Antigen Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Prostate Specific Antigen Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Prostate Specific Antigen Sales Market Share by Application (2020-2025)
 Table 63. Global Prostate Specific Antigen Sales Market Share by Application (2026-2031)
 Table 64. Global Prostate Specific Antigen Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prostate Specific Antigen Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prostate Specific Antigen Revenue Market Share by Application (2020-2025)
 Table 67. Global Prostate Specific Antigen Revenue Market Share by Application (2026-2031)
 Table 68. Global Prostate Specific Antigen Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Prostate Specific Antigen Price (USD/Pcs) by Application (2026-2031)
 Table 70. Advaxis, Inc. Company Information
 Table 71. Advaxis, Inc. Description and Business Overview
 Table 72. Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Advaxis, Inc. Prostate Specific Antigen Product
 Table 74. Advaxis, Inc. Recent Developments/Updates
 Table 75. Aeterna Zentaris Inc. Company Information
 Table 76. Aeterna Zentaris Inc. Description and Business Overview
 Table 77. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Aeterna Zentaris Inc. Prostate Specific Antigen Product
 Table 79. Aeterna Zentaris Inc. Recent Developments/Updates
 Table 80. Bavarian Nordic A/S Company Information
 Table 81. Bavarian Nordic A/S Description and Business Overview
 Table 82. Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bavarian Nordic A/S Prostate Specific Antigen Product
 Table 84. Bavarian Nordic A/S Recent Developments/Updates
 Table 85. Curevac AG Company Information
 Table 86. Curevac AG Description and Business Overview
 Table 87. Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Curevac AG Prostate Specific Antigen Product
 Table 89. Curevac AG Recent Developments/Updates
 Table 90. GenSpera, Inc. Company Information
 Table 91. GenSpera, Inc. Description and Business Overview
 Table 92. GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. GenSpera, Inc. Prostate Specific Antigen Product
 Table 94. GenSpera, Inc. Recent Developments/Updates
 Table 95. Inovio Pharmaceuticals, Inc. Company Information
 Table 96. Inovio Pharmaceuticals, Inc. Description and Business Overview
 Table 97. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product
 Table 99. Inovio Pharmaceuticals, Inc. Recent Developments/Updates
 Table 100. OncBioMune Pharmaceuticals Inc. Company Information
 Table 101. OncBioMune Pharmaceuticals Inc. Description and Business Overview
 Table 102. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product
 Table 104. OncBioMune Pharmaceuticals Inc. Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Prostate Specific Antigen Distributors List
 Table 108. Prostate Specific Antigen Customers List
 Table 109. Prostate Specific Antigen Market Trends
 Table 110. Prostate Specific Antigen Market Drivers
 Table 111. Prostate Specific Antigen Market Challenges
 Table 112. Prostate Specific Antigen Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostate Specific Antigen
 Figure 2. Global Prostate Specific Antigen Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostate Specific Antigen Market Share by Type: 2024 & 2031
 Figure 4. G-115 Product Picture
 Figure 5. INO-5150 Product Picture
 Figure 6. ADXS-PSA Product Picture
 Figure 7. AEZS-120 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Prostate Specific Antigen Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Prostate Specific Antigen Market Share by Application: 2024 & 2031
 Figure 11. Prostate Cancer
 Figure 12. Metastatic Hormone Refractory Prostate Cancer
 Figure 13. Others
 Figure 14. Global Prostate Specific Antigen Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prostate Specific Antigen Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Prostate Specific Antigen Sales (2020-2031) & (K Pcs)
 Figure 17. Global Prostate Specific Antigen Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Prostate Specific Antigen Report Years Considered
 Figure 19. Prostate Specific Antigen Sales Share by Manufacturers in 2024
 Figure 20. Global Prostate Specific Antigen Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Prostate Specific Antigen Players: Market Share by Revenue in Prostate Specific Antigen in 2024
 Figure 22. Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Prostate Specific Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Prostate Specific Antigen Sales Market Share by Country (2020-2031)
 Figure 25. North America Prostate Specific Antigen Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Prostate Specific Antigen Sales Market Share by Country (2020-2031)
 Figure 29. Europe Prostate Specific Antigen Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Prostate Specific Antigen Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Prostate Specific Antigen Revenue Market Share by Region (2020-2031)
 Figure 37. China Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Prostate Specific Antigen Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Prostate Specific Antigen Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Prostate Specific Antigen Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Prostate Specific Antigen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Prostate Specific Antigen by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Prostate Specific Antigen by Type (2020-2031)
 Figure 59. Global Prostate Specific Antigen Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Prostate Specific Antigen by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Prostate Specific Antigen by Application (2020-2031)
 Figure 62. Global Prostate Specific Antigen Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Prostate Specific Antigen Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Testicular Cancer Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26B6701
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Biomarker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12M6232
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G5907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B2445
Mon Sep 08 00:00:00 UTC 2025

Add to Cart